The dependence on lutropin of the synthesis of a proposed short-half-life protein regulator involved in Leydig-cell steroidogenesis was investigated. This was carried out by determining the effect of the protein-synthesis inhibitor cycloheximide, added before and during incubations with lutropin (and/or dibutyryl cyclic AMP), on the rate of testosterone production in suspensions of purified Leydig cells from adult rat testes. The Leydig cells were preincubated in Eagle's medium for 2.5h followed by 30min incubation with and without cycloheximide. The inhibitor was removed by washing the cells and then lutropin was added and testosterone concentrations were determined after incubation of the cells at 32°C. No significant effect of cycloheximide pretreatment on lutropin-stimulated steroidogenesis was found during 60min incubation. This was in contrast with the complete inhibiting effect of cycloheximide when it was added with the lutropin. The pretreatment experiments with cycloheximide were repeated in the presence of dibutyryl cyclic AMP and elipten phosphate (to inhibit cholesterol side-chain cleavage) followed by incubation with lutropin. After 5, 10, 20 and 60min of incubation, testosterone concentrations were 61±3, 46±3, 27±4 and 18±4% lower than in the cells pretreated without cycloheximide respectively (means±s.e.m., n=4–6). In the cells not pretreated with cycloheximide and in the absence of lutropin, testosterone production increased from 1.36±0.5 to 36.5±1.0ng/106 cells during 20min of incubation, after which no further increase occurred. Pretreatment of the cells with cycloheximide decreased these testosterone concentrations by 65, 46, 42 and 36% in the 5, 10, 20 and 60min incubations respectively (mean values, n=2–4). It is apparent from these results that inhibition of steroidogenesis only occurs if protein synthesis is inhibited in the presence of lutropin or cyclic AMP. A new hypothesis is put forward to explain these findings: it is proposed that lutropin affects the stability of a precursor of a regulator protein by converting it from a stable (inactive) to an unstable (active) form with a short half-life.
Skip Nav Destination
Follow us on Twitter @Biochem_Journal
Article navigation
October 1979
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkAdvertising
Research Article|
October 15 1979
The mechanism of action of lutropin on regulator protein(s) involved in Leydig-cell steroidogenesis
Brian A. Cooke;
Brian A. Cooke
*Department of Biochemistry (Division of Chemical Endocrinology), Medical Faculty, Erasmus University, Rotterdam, The Netherlands
†Department of Biochemistry, Royal Free Hospital School of Medicine, University of London, London WC1N 1BP, U.K.
Search for other works by this author on:
L. Monica Lindh;
L. Monica Lindh
*Department of Biochemistry (Division of Chemical Endocrinology), Medical Faculty, Erasmus University, Rotterdam, The Netherlands
Search for other works by this author on:
Henk J. Van Der Molen
Henk J. Van Der Molen
*Department of Biochemistry (Division of Chemical Endocrinology), Medical Faculty, Erasmus University, Rotterdam, The Netherlands
Search for other works by this author on:
Publisher: Portland Press Ltd
Online ISSN: 1470-8728
Print ISSN: 0264-6021
© 1979 London: The Biochemical Society
1979
Biochem J (1979) 184 (1): 33–38.
Citation
Brian A. Cooke, L. Monica Lindh, Henk J. Van Der Molen; The mechanism of action of lutropin on regulator protein(s) involved in Leydig-cell steroidogenesis. Biochem J 15 October 1979; 184 (1): 33–38. doi: https://doi.org/10.1042/bj1840033
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Follow us on Twitter @Biochem_Journal
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
View past webinars > |